|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/543 | (2006.01) |
| G01N 33/564 | (2006.01) |
| (11) | Number of the document | 3529619 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17804980.5 |
| Date of filing the European patent application | 2017-10-19 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057377 |
| Date | 2017-10-19 |
| (87) | Number | WO 2018/075761 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662410028 P | 2016-10-19 | US |
| (72) |
DYSINGER, Mark , US
MA, Mark , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | A METHOD OF QUANTITATING UNBOUND C5A IN A SAMPLE |
| A METHOD OF QUANTITATING UNBOUND C5A IN A SAMPLE |